Europe Diagnostics Market By Product (Instruments, Reagents, Software & Services), By Technology (Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Microbiology, Others), By Application, By End User, By Country, Competition, Forecast & Opportunities, 2028

Growing Incidences of Various Diseases, Along with Extensive Technological Advancements in the Country, is Likely to Propel the Growth of the Market.

Europe diagnostics market is expected to grow at an impressive rate during the forecast period, 2024-2028. Growing incidences of various diseases, along with extensive technological advancements in the country, is likely to propel the growth of the market. Clinical diagnostics has to open up new possibilities for early prevention and intervention by identifying the risk factors and early warning indications in a patient. As a result, it is projected that the entire market will continue to grow as the occurrences of chronic illnesses rise. Also, there is an increase in In-vitro diagnostic tests as well as increasing demand for genetic testing, which, in turn, is surging the growth of the market.

Additionally, the growing demand for Point-of-Care testing is a major factor in the market’s growth. This can be attributed to surging demand for self-testing diagnostics and also the patient awareness regarding early diagnosis of diseases. The growing popularity of personalized medicine among people for the treatment of several chronic diseases is likely to create lucrative opportunities for market growth over the next few years.

Growing Prevalence of Several Diseases and Disorders

Growing incidences and prevalence of lifestyle disorders such as hypertension, cardiovascular diseases, cancer, and diabetes, among others, are expected to bolster the growth of the market. According to the Global Cancer Observatory report, in 2020, 4,398,443 European people were suffering from cancer, out of which 1,955,231 people lost their lives due to cancer. Additionally, people are becoming more aware of the early diagnosis and treatment of chronic diseases, which, in turn, surges the demand for diagnostic tests. Therefore, these factors are anticipated to facilitate the growth of the market.

Increasing Aging Population

The rising geriatric population is increasing the risk of getting several diseases, including heart strokes, cancer, cardiovascular diseases, neurological disorders, and diabetes in the country is facilitating the growth of the market. For instance, in 2021, Europe has the largest proportion of the aging population with 19%, where Germany is the country that contributed the most to the older population with 17.78 million, followed by Italy with 13.76 million, France with 13.16 million, and the United Kingdom with 12.24 million.

Recent Developments

• In 2021, Roche introduced its Cobas Pulse System in select countries accepting CE mark approval in Europe. The item is a networked point-of-care solution from Roche Diagnostics' latest generation. The most recent release offers expert blood glucose management.
• In 2021, Hologic announced the European launch of Genius™ Digital Diagnostics System for cervical cancer screening. It is the next generation of cervical cancer screening that merges deep learning-based artificial intelligence (AI) with advanced volumetric imaging technology to assist in identifying pre-cancerous lesions and cervical cancer cells in women. It was developed to offer actionable insights and to improve workflow and lab efficiency, which primarily focus on eradicating cervical cancer.

Market Segmentation

Europe diagnostics market is segmented into product, technology, application, end-user, company, and region. Based on product, the market is categorized into instruments, reagents, and software & services. Based on technology, the market is divided into immunoassay, hematology, clinical chemistry, molecular diagnostics, microbiology, and others. Based on application, the market can be divided into infectious diseases, diabetes, oncology, cardiology, nephrology, and others. Based on end users, the market is bifurcated into hospitals & clinics, diagnostic centers & laboratories, and others. In terms of countries, the market is segmented into France, Germany, United Kingdom, Italy, Spain, Finland, Greece, Portugal, Bulgaria, and Croatia.

Market Players

Roche Diagnostics GmbH, Ortho Clinical Diagnostics., Abbott Laboratories, Inc., Hologic, Inc. (Gen-Probe), Qiagen N.V., Bio-Rad Laboratories, Inc., Quidel Corporation, Becton, Dickinson (BD) Company, Inc., bioMerieux, Inc., and Siemens Healthcare GmbH are some of the leading companies operating in the Europe Diagnostics Market.

Report Scope:

In this report, Europe diagnostics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Europe Diagnostics Market, By Product:

• Instruments
• Reagents
• Software & Services

Europe Diagnostics Market, By Technology:

• Immunoassay
• Hematology
• Clinical Chemistry
• Molecular Diagnostics
• Microbiology
• Others

Europe Diagnostics Market, By Application:

• Infectious Diseases
• Diabetes
• Oncology
• Cardiology
• Nephrology
• Others

Europe Diagnostics Market, By End User:

• Hospitals & Clinics
• Diagnostic Centers & Laboratories
• Others

Europe Diagnostics Market, By Country:

• France
• Germany
• United Kingdom
• Italy
• Spain
• Finland
• Greece
• Portugal
• Bulgaria
• Croatia.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Europe diagnostics market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.


This product will be delivered within 1-3 business days.